Mao Jianhua, Zhang Yang, Du Lizhong, Dai Yuwen, Gu Weizhong, Liu Ai'min, Shang Shiqiang, Liang Li
Department of Nephrology, Zhejiang University School of Medicine, Children's Hospital, Hangzhou 310006, Zhejiang Province, PR China.
Pediatr Res. 2007 Jan;61(1):117-22. doi: 10.1203/01.pdr.0000250041.19306.3d.
Recent discoveries indicate that the molecules in glomerular podocytes and slit diaphragms may play an important role in the development of proteinuria and nephrotic syndrome. Mutational analyses of NPHS1 and NPHS2 were performed to verify this hypothesis in sporadic nephrotic syndrome (NS) patients. Clinical characteristics and DNA samples were collected from 38 Chinese children with sporadic steroid-sensitive NS, 22 with steroid-resistant NS and 30 controls. Direct sequencing was performed after PCR amplification of all 29 and 8 exons of the NPHS1 and NPHS2 genes, respectively. In NPHS1, 4 patients had heterozygous missense mutations leading to amino acid substitutions (R800C, Q453R). Furthermore, 3 known single nucleotide polymorphism (SNP) were found (T741T, V763V, S1105S). In NPHS2, 3 patients had novel heterozygous allelic variants leading to amino acid substitutions (S206I, E188D), while 1 patient was found to carry a novel nonsense mutation leading to a truncated protein product (Glu237STOP). Two known polymorphisms were also found (A318A, L346L). The results demonstrate that NPHS1 and NPHS2 mutations are also present in Chinese sporadic NS patients, suggesting that genetic changes of nephrin and podocin may play pathogenetic roles in some patients with sporadic steroid resistant NS.
近期的研究发现表明,肾小球足细胞和裂孔隔膜中的分子可能在蛋白尿和肾病综合征的发生发展中起重要作用。对NPHS1和NPHS2进行突变分析,以在散发性肾病综合征(NS)患者中验证这一假设。收集了38例中国散发性类固醇敏感型NS儿童、22例类固醇抵抗型NS儿童和30例对照的临床特征及DNA样本。分别对NPHS1基因的全部29个外显子和NPHS2基因的8个外显子进行PCR扩增后进行直接测序。在NPHS1中,4例患者有导致氨基酸替代的杂合错义突变(R800C、Q453R)。此外,发现了3个已知的单核苷酸多态性(SNP)(T741T、V763V、S1105S)。在NPHS2中,3例患者有导致氨基酸替代的新型杂合等位基因变异(S206I、E188D),而1例患者被发现携带导致蛋白质产物截短的新型无义突变(Glu237STOP)。还发现了2个已知的多态性(A318A、L346L)。结果表明,中国散发性NS患者中也存在NPHS1和NPHS2突变,提示nephrin和podocin的基因改变可能在一些散发性类固醇抵抗型NS患者中起致病作用。